INTELLIA THERAPEUTICS, INC. (NTLA) Gross profit 2018–2021
INTELLIA THERAPEUTICS, INC. (NTLA) annual gross profit history from SEC filings — each fiscal year as reported.
$33.1MFY2021 · since FY2018: $30.4M → $33.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | $33.1M | -43.0% |
| FY2020 | $58.0M | +34.5% |
| FY2019 | $43.1M | +41.6% |
| FY2018 | $30.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NTLA financial trends
NTLA RevenueNTLA Net incomeNTLA Net marginNTLA Gross marginNTLA Operating incomeNTLA Operating marginNTLA Operating cash flowNTLA Free cash flowNTLA Capital expendituresNTLA Return on equityNTLA Stock buybacksNTLA Dividends paidNTLA Total assetsNTLA Total liabilitiesNTLA Shareholders’ equityNTLA overview →